Alleviant ALLAY-HF Study
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 700 participants.
Also called NCT05685303
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 700 participants
- Sponsor
- Alleviant Medical, Inc.
- Registry
-
NCT05685303
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States, Australia, Austria, Belgium, Bulgaria, Canada, Czechia, Georgia, Germany, Israel, Italy, New Zealand, Poland, Spain
- Registry status
- Recruiting
Technical summary
Registry record NCT05685303. Randomized; double masking; primary purpose treatment. Start 2023-01-10 (actual); primary completion 2027-12-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Alleviant ALLAY-HF Study
- Condition
- Heart Failure
- Intervention (Device)
- Alleviant ALV1 System
- Intervention (Other)
- Sham-Control
- Lead sponsor
- Alleviant Medical, Inc.
Record details
- Record id
cardio:ct-nct05685303- Content hash
7bb91d6042987a463c20cb8fd07bac5305ff7b1436a0eeb91f54c5e42273f0c3